Importance of gastrointestinal motility disorders

Practical Gastroenterology

Volumn 30, Issue 9, 2006, Pages 23-40

  Parkman, Henry P ^a   Doma, Sivaprasad ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINAL DYSMOTILITY; PATHOPHYSIOLOGY; PREVALENCE; QUALITY OF LIFE; REVIEW; SYMPTOMATOLOGY;

EID: 33749360614     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Quigley EM. Gastrointestinal motility: an academic and research perspective. Dig Dis, 2006;24:218-220.
2. Lacy BE, Weiser K. Gastrointestinal motility disorders: an update. Dig Dis, 2006;24:228-242.
3. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and Societal impact of upper gastrointestinal disorders in the United States. Clinical Gastro Hepatology, 2005;3:543-562.
4. Higgins PDR, Johanson JF. Epidemiology of constipation in North America: A systematic review. Am J Gastroenterology, 2004;101:750-759.
5. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, Sandler RS. Digestive and Liver Diseases Statistics, 2004. Gastroenterology, 2004;126:1448-1453.
6. Chang L. Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharm Ther, 2004;20 (Suppl 7):31-39.
7. Moayyedi P, Mason J. Clinical and economic consequences of dyspepsia in the community. Gut, 2002;50 (Suppl 4):10-12.
8. El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther, 2003;18:387-391.
9. Farup CE, Williams GR, Leidy NK, Helbers L, Murray M, Quigley EMM. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care, 1998;21:1699-1706.
10. Xing J, Chen JD. Alterations of gastrointestinal motility in obesity. Obesity Research, 2004;12(11):1723-32.
11. Farrokhyar F, Marshall JK, Cawdron R, Donnelly M, Ling A, Irvine EJ. Prevalence of functional gastrointestinal disorders (FGID) in inflammatory bowel disease (IBD). Can J Gastroenterol, 2001;15(suppl A):57A-58A.
12. O'Leary C, Wieneke P, Buckley S, O'Regan P, Cronin CC, Quigley EM, Shanahan F. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol, 2002;97(6):1463-1467.
13. Neal KR, Hebden J, Spiller R., Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. Br Med J, 1997;314:779-782.
14. Lacy BE, Weiser K. Gastric motility, gastroparesis, and gastric stimulation. Surg Clin North Am, 2005;85:967-987.
15. AASLD, ACG, AGA, ASGE. Training the Gastroenterologists of the Future: The Gastroenterology Core Curriculum. Gastroenterology, 2003;124:1055-1104.
16. Brookes SJ, Cook IJ, Costa M, de Giogio R, Dent J, Grundy D, Sander KM, Schemann M, Shea-Donohue T, Smith TK, Tonina M. Education project for pathophysiology of gastrointestinal motility. Neurogastroenterol Motil, 2005;17 Suppl 3:2-3.
17. Costa M, Sanders KM, Schemann M, Smith TK, Cook IJ, de Giorgia R, Dent J, Grundy D, Shea-Donohue T, Tonini M, Brookes SJ. A teaching module on cellular control of small intestinal motility. Neurogastroenterol Motil, 2005;17 Suppl 3:4-19.
18. Micci MA, Kahrig KM, Simmons RS, Sarna SK, Espejo-Navarro MR, Pasricha PJ. Neural stem cell transplantation in the stomach rescues gastric function in neuronal nitric oxide synthase-deficient mice. Gastroenterology, 2005;129(6):1817-1824.